|
|
Magnetic resonance and ultrasound imaging as biomarkers for detection and monitoring of Parsonage-Turner Syndrome (PTS) |
| 1 R21 TR003033-01A1 |
SNEAG, DARRYL |
NCATS |
2020 |
|
|
Development and validation of clinical outcome assessments in LGMD2A |
| 1 R21 TR003184-01 |
JOHNSON, NICHOLAS ELWOOD |
NCATS |
2020 |
|
|
Network mechanisms of impaired adult hippocampal neurogenesis in a mouse model of prenatal alcohol exposure |
| 1 R01 AA027462-01A1 |
CUNNINGHAM, LEE ANNA |
NIAAA |
2020 |
|
|
The Pittsburgh ADHD Longitudinal Study: Predicting alcohol misuse, problems and disorder in mid-adulthood |
| 1 R01 AA027494-01A1 |
MOLINA, BROOKE S G |
NIAAA |
2020 |
|
|
Mechanisms underlying diverse effects of low-dose embryonic ethanol on development and function of hypocretin/orexin neurons |
| 1 R01 AA027653-01A1 |
LEIBOWITZ, SARAH F |
NIAAA |
2020 |
|
|
Reassessing FASD: Novel Approaches for Evaluating Exposure, Diagnosis and Outcomes in Children Prenatally Exposed to Alcohol |
| 1 R01 AA027785-01A1 |
BANDOLI, GRETCHEN E |
NIAAA |
2020 |
|
|
A Randomized, Double-Blind, Placebo-controlled Clinical Trial of Choline Supplementation during Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Development |
| 1 R01 AA028053-01 |
JACOBSON, SANDRA W |
NIAAA |
2020 |
|
|
HERITABLE, EPIGENETIC EFFECTS OF PATERNAL ALCOHOL USE ON FASD PHENOTYPES |
| 1 R01 AA028219-01 |
GOLDING, MICHAEL C |
NIAAA |
2020 |
|
|
Prenatal alcohol/cannabinoid co-exposures and fetal brain development |
| 1 R01 AA028406-01 |
MIRANDA, RAJESH C |
NIAAA |
2020 |
|
|
Role of exosomes in the coordinated migration of neural crest cells and placodes and ethanol-induced teratogenesis |
| 1 R01 AA028435-01 |
CHEN, SHAO-YU |
NIAAA |
2020 |
